IP Library Granted Patent US 9,061,027
Granted Patent B2
US 9,061,027 · App. 11/660,012 · Granted Jun 23, 2015

Enhanced delivery of drug compositions to treat life threatening infections

Inventors: James E. Hitt (Midland, MI); True L. Rogers (Midland, MI); Ian B. Gillespie (Linden, MI); Brian D. Scherzer (Midland, MI); Paula C. Garcia (Midland, MI); Nicholas S. Beck (Midland, MI); Christopher J. Tucker (Midland, MI); Timothy J. Young (Bay City, MI); David A. Hayes (Midland, MI); Robert O. Williams, III (Austin, TX); Keith P. Johnston (Austin, TX); Jason T. McConville (Austin, TX); Jay I. Peters (San Antonio, TX); Robert Talbert (San Antonio, TX); David Burgess (San Antonio, TX)
Assignee: Board of Regents, the University of Texas System
A61K31/496A61K9/0073
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,061,027
App. No.
11/660,012
Granted
Jun 23, 2015
Kind
B2
Abstract

Inhalable compositions are described. The inhalable compositions comprise one or more respirable aggregates, the respirable aggregates comprising one or more poorly water soluble active agents, wherein at least one of the active agents reaches a maximum lung concentration (C max ) of at least about 0.25 μg/gram of lung tissue and remains at such concentration for a period of at least one hour after being delivered to the lung. Methods for making such compositions and methods for using such compositions are also disclosed.

Claims (8)

1. An inhalable composition comprising porous, respirable nanoparticle aggregates suitable for deep lung deposition, the aggregates comprising one or more active agents, wherein at least one of the active agents is an azole antifungal agent, wherein the respirable aggregates comprise droplets that have a mass median aerodynamic diameter of from about 1 μm and about 5 μm, and further wherein at least one of the active agents reaches a maximum lung concentration (C max ) of at least 0.5 μg/gram of lung tissue and remains at such concentration for a period of at least two hours after being delivered to the lung.

2. The composition of claim 1 , wherein the respirable aggregates have a density from about 0.1 g/mL to about 5 g/mL.

3. The composition of claim 1 , wherein the antifungal agent is natamycin, flucytosine, miconazole, fluconazole, itraconazole, clotrimazole, econazole, miconazole, ravuconazole, oxiconazole, sulconazole, terconazole, tioconazole, fenticonazole, bifonazole, oxiconazole, ketoconazole, isoconazole, tolnaftate, amorolfine, terbinafine, voriconazol, posaconazol, or the pharmacologically acceptable organic and inorganic salts or metal complexes or mixture thereof.

4. The composition according to claim 3 , wherein the antifungal agent is itraconazole.

5. The composition of claim 1 , wherein aggregates comprised in the composition have a porosity of from 10 percent to 80 percent.

6. The composition of claim 5 , wherein the aggregates have a porosity of at least 40 percent.

7. The composition of claim 6 , wherein the aggregates have a porosity of at least 60 percent.

8. The composition of claim 1 , wherein aggregates comprised in the composition have a surface area of greater than 1 m 2 /g.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 11, 2014
From: HITT, JAMES E.; ROGERS, TRUE L.; SCHERZER, BRIAN D.; GILLESPIE, IAN B.; GARCIA, PAULA C.; BECK, NICHOLAS S.; TUCKER, CHRISTOPHER J.; YOUNG, TIMOTHY J.; HAYES, DAVID A.
To: THE DOW CHEMICAL COMPANY
Reel/Frame 033718/0041 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 11, 2014
From: WILLIAMS, ROBERT O., III; MCCONVILLE, JASON T.; BURGESS, DAVID; JOHNSTON, KEITH P.; PETERS, JAY I.; TALBERT, ROBERT
To: BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
Reel/Frame 033718/0107 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 5, 2009
From: DOW GLOBAL TECHNOLOGIES INC.
To: BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
Reel/Frame 023327/0934 →
Continuity (2)
Provisional Application 60605179 · Aug 27, 2004
Related Publication 20070287675A1 · Dec 13, 2007